Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Open accessThe DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Abstract
Paget disease of bone (PDB) is a common disorder characterized by focal and disorganized increases of bone turnover. Genetic factors are important in the pathogenesis of PDB. We and others recently mapped the third locus associated with the disorder, PDB3, at 5q35-qter. In the present study, by use of 24 French Canadian families and 112 unrelated subjects with PDB, the PDB3 locus was confined to approximately 300 kb. Within this interval, two disease-related haplotype signatures were observed in 11 families and 18 unrelated patients. This region encoded the ubiquitin-binding protein sequestosome 1 (SQSTM1/p62), which is a candidate gene for PDB because of its association with the NF-kappaB pathway. Screening SQSTM1/p62 for mutations led to the identification of a recurrent nonconservative change (P392L) flanking the ubiquitin-associated domain (UBA) (position 394-440) of the protein that was not present in 291 control individuals. Our data demonstrate that two independent mutational events at the same position in SQSTM1/p62 caused PDB in a high proportion of French Canadian patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [403]
In the citing paper
“SQSTM1 mutations are not only a rare cause of ALS-FTD, accounting for ~1-3.5% of cases with or without family history [123–125], but also Paget’s disease of bone (PDB), a chronic and progressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [126]
Citations
Cites
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599 · cited 4×
“Cosegregation of the P392L variant with the phenotype, its absence in 86 spouses and 205 individuals from the general population, the nonconservative nature of the amino acid substitution, and the conservation of the UBA domain, including the P392 residue, among other species (mouse and rat) provided support for the i…”
BackgroundInfluentialA comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928 · cited 1×
“markers (Dib et al. 1996), present within this interval, using an ePCR approach (Schuler 1998).”
MethodSelf-citationHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“Osteoclast formation and activation involve the receptor activator of NF-kB (RANK) pathway, a tumor-necrosis factor (TNF) family member (Hsu et al. 1999).”
BackgroundThe staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263 · cited 1×
“Both strands were analyzed using STADEN package 1.1 (Staden 1996).”
MethodInfluentialSobel, E. M., & Lange, K. L. (1996) · PubMed Central · Cited by 1,176
Principles and Practice of Endocrinology and Metabolism.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-816_4 · Cited by 803
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635 · cited 6×
“1999), and TRAF6-deficient mice exhibit severe osteopetrosis and are defective in osteoclast formation because of impaired signaling induced by RANK (Naito et al. 1999).”
BackgroundInfluentialMutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., MacPherson, H., Wallace, R. G. H., van Hul, W., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481 · cited 1×
“Activating mutations of the TNFRSF11A gene encoding this receptor have been found to be responsible for FEO and rare cases of early-onset familial PDB (Hughes et al. 2000).”
BackgroundThe atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluentialThe interaction of p62 with RIP links the atypical PKCs to NF-kappa B activation
Sanz, L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3044 · Cited by 410 · cited 7×
“The functional importance of SQSTM1/p62 in NF-kB activation has been further highlighted by the observation that its depletion severely abrogated NF-kB activation through the TNFa or IL-1 pathways (Sanz et al. 1999, 2000).”
BackgroundInfluential
Research works printed but not linked: 1
- Glaser, 1999, Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism, Hum Mutat, 14, 23, 10.1002/(SICI)1098-1004(1999)14:1<23::AID-HUMU3>3.0.CO;2-# · doi:10.1002/(sici)1098-1004(1999)14:1<23::aid-humu3>3.0.co;2-#
Cited by
Items 301–400 of 563
Involvement of kinase PKC-zeta in the p62/p62P392L-driven activation of NF-κB in human osteoclasts
Chamoux, E., McManus, S., Laberge, G., Bisson, M., & Roux, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.008 · Cited by 24
Alternative splicing in osteoclasts and Paget’s disease of bone
Klinck, R., Laberge, G., Bisson, M., McManus, S., Michou, L., Brown, J. P., & Roux, S. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0098-1 · Cited by 23
“Exons 7 and 8 of the gene encoding SQSTM1/p62 had been previously sequenced in every donor and patient [13].”
Self-citationDetection of SQSTM1/P392L post-zygotic mutations in Paget’s disease of bone
Guay-Bélanger, S., Picard, S., Gagnon, É., Morissette, J., Siris, E. S., Orcel, P., Brown, J. P., & Michou, L. (2014) · Human Genetics · doi:10.1007/s00439-014-1488-3 · Cited by 23
“…the SQSTM1/P392L mutation in PDB patients In this study, we only investigated the SQSTM1/P392L mutation, the most common mutation associated with PDB so far, since this mutation occurs at a hypermutable CpG dinucleotide sequence, a mutational hotspot (Laurin et al. 2002; Morissette et al. 2006).”
BackgroundInfluentialSelf-citationLorenzo, J. A., CANALIS, E. M., & Raisz, L. G. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00029-8 · Cited by 23
Sequestosome 1/p62 enhances chronic skin inflammation
Sukseree, S., Bakiri, L., Palomo-Irigoyen, M., Uluçkan, Ö., Petzelbauer, P., & Wagner, E. F. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.02.028 · Cited by 19
Gianfrancesco, F., Rendina, D., Merlotti, D., Esposito, T., Amyere, M., Formicola, D., Muscariello, R., FILIPPO, G. D., Strazzullo, P., Nuti, R., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1750 · Cited by 19
“In a previous study, we demonstrated that the region of Campania is associated with an enhanced clinical severity of PDB with respect to the other regions,((8)) and thus we preferred to compare the clinical characteristics of patients from this PDB/GCT pedigree to a cohort of unrelated patients from the same region.”
BackgroundResultGenetic defects of autophagy linked to disease
Fraiberg, M., & Elazar, Z. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.001 · Cited by 24
Corral-Gudino, L., del Pino‐Montes, J., García‐Aparicio, J., Corral, E., Montilla, C. A., & González‐Sarmiento, R. (2005) · Bone · doi:10.1016/j.bone.2005.09.010 · Cited by 22
“Recently, mutations in the sequestosome (SQSTM1/p62) gene have been identified in familial PBD, as well as in 5–15% of patients with no family history [26–28].”
BackgroundMao, Y., Kuo, S.-W., Chen, L., Heckman, C. J., & Jiang, M. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172246 · Cited by 20
Lewiecki, E. M., Bilezikian, J. P., Laster, A. J., Miller, P. D., Recker, R. R., Russell, R. G. G., & Whyte, M. P. (2010) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2009.12.003 · Cited by 19
Paget’s disease—A VDR coactivator disease?
Kurihara, N., Ishizuka, S., Demulder, A., Menaa, C., & Roodman, G. D. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.03.023 · Cited by 19
Falchetti, A., Stefano, M. D., Marini, F., Monte, F. D., Gozzini, A., Masi, L., Tanini, A., Amedei, A., Carossino, A., Isaia, G., et al. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1828 · Cited by 20
“NFκB is also the potential molecular target of the mechanism underlying the altered osteoclastogenesis seen in PDB patients carrying mutated sequences in the UBA domain of the p62/SQSTM1 gene [2-12].”
BackgroundInfluentialPaget's Disease of Bone: Approach to Its Historical Origins
Bueyes, L. R. M., & Fernández, M. D. C. S. (2017) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2016.02.009 · Cited by 19
Jackson, K. L., Lin, W.-L., Miriyala, S., Dayton, R. D., Panchatcharam, M., McCarthy, K. J., Castanedes‐Casey, M., Dickson, D. W., & Klein, R. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169291 · Cited by 20
Sharaf, A. L., Mensching, L., Keller, C., Rading, S., Scheffold, M., Palkowitsch, L., Djogo, N., Rezgaoui, M., Kestler, H. A., Moepps, B., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00224 · Cited by 20
“The latter is characterized by increased bone remodeling in focal areas leading to bone pain, deformities and fractures (Laurin et al., 2002; Seitz et al., 2008).”
BackgroundInfluentialCronin, O., Subedi, D., Forsyth, L., Goodman, K., Lewis, S. C., Keerie, C., Walker, A., Porteous, M. E., Cetnarskyj, R., Ranganath, L. R., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4007 · Cited by 21
“Genetic factors play a key role in PDB and the most important susceptibility gene is SQSTM1.((2,3)) Protein coding mutations of SQSTM1, which predominantly affect the ubiquitin-associated (UBA) domain, have been detected in between 40% and 50% of people with a family history of PDB and up to 15% of those who are unawa…”
BackgroundAlmeida, M. R., Letra, L., Pires, P., SANTOS, A. C. D. S., Rebelo, O., Guerreiro, R. J., van der Zee, J., Broeckhoven, C. V., & Santana, I. J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.015 · Cited by 21
“Interestingly, it was also identified in FTLD, ALS patients (with or without concomitant PDB) and in control individuals at low frequency (<1%) (Fecto et al., 2011; Laurin et al., 2002; Vadlamudi et al., 1996).”
BackgroundPhillips, J., Subedi, D., Lewis, S. C., Keerie, C., Cronin, O., Porteous, M. E., Moore, D., Cetnarskyj, R., Ranganath, L. R., Selby, P. L., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224990 · Cited by 22
Kottlors, M., Moske-Eick, O., Huebner, A., Krause, S., Mueller, K. M., Kreß, W., Schwarzwald, R., Bornemann, A., Haug, V., Heitzer, M., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.12.008 · Cited by 17
“Of note is that p62/SQSTM1 is overexpressed in sporadic inclusion body myositis and mutations in the SQSTM1 gene cause PDB3 [39,42].”
BackgroundPharmacotherapy of Paget's disease of bone
Reid, I. R. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.662486 · Cited by 20
Evolution of understanding of genetics of Paget?s disease of bone and related diseases
Takata, S., Yasui, N., Nakatsuka, K., & Ralston, S. H. (2004) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-004-0518-y · Cited by 15
“Positional cloning studies have recently identified mutations in the sequestosome 1 (SQSTM1) gene as the cause of late-onset 5q35-linked PDB [26,27].”
BackgroundPenolazzi, L., Magri, E., Lambertini, E., Calò, G., Cozzani, M., Siciliani, G., Piva, R., & Gambari, R. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.5.807 · Cited by 17
“Overactivity of OCs is described in several human bone diseases, such as Paget's disease of bone, expansile skeletal hyperphosphatasia and familiar expansile osteolysis (13,14).”
Nakamura, Y., Ito, Y., Wakimoto, N., Kakegawa, E., Uchida, Y., & Bessho, M. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.86 · Cited by 16
SQSTM1-mediated clearance of cytoplasmic mutant TARDBP/TDP-43 in the monkey brain
Yin, P., Bai, D., Deng, F., Zhang, C., Jia, Q., Zhu, L., Chen, L., Li, B., Guo, X., Ye, J., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.2013653 · Cited by 17
“Mutations on the SQSTM1 gene were firstly identified in Paget disease of bone [25], and more recently identified in both ALS and FTLD patients [21,26– 28].”
BackgroundReprint: Paget's disease of bone
Cundy, T., & Reid, I. R. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.06.011 · Cited by 20
Heinen, C., Garner, T. P., Long, J., Böttcher, C., Ralston, S. H., Cavey, J. R., Searle, M. S., Layfield, R., & Dantuma, N. P. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.018 · Cited by 17
“Mutations in the ubiquitin binding protein p62, also known as sequestosome-1 (SQSTM1), have been genetically linked to sporadic and familial cases of PDB [11].”
BackgroundRole of the p62 Protein in the Formation of Neuropathological Cytoplasmic Inclusions
Kuusisto, E. (2004) · Cited by 29
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
Chen, K. S.-M., Kwon, W. S., Kim, J., Heo, S. J., Kim, H. S., Kim, H. K., Kim, S. H., Lee, W. S., Chung, H. C., Rha, S. Y., et al. (2016) · Molecular Case Studies · doi:10.1101/mcs.a000992 · Cited by 16
Genetic architecture of amyotrophic lateral sclerosis: a comprehensive review
Yuan, L., Yang, Y., Guo, Y., & Deng, H. (2025) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2025.05.008 · Cited by 19
di Carlo, F. S., Pazzaglia, L., Mumm, S. R., Benassi, M. S., Chiara, A. D., Franchi, A., Parafioriti, A., Righi, A., Esposito, T., Whyte, M. P., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3993 · Cited by 16
“Germline mutations in the SQSTM1 gene are responsible for familial and sporadic PDB in 40% and 10% of cases, respectively.((5,6)) These mutations cause classical PDB in which the”
BackgroundLessard, S., Chao, M. J., Reis, K., FinnGen, Rajpal, D. K., Shankara, S., Sloane, J., Palta, P., Klinger, K. W., de Rinaldis, E., et al. (2024) · BMC Genomics · doi:10.1186/s12864-024-10971-2 · Cited by 22
“…to monogenic disorders including PSEN1 with Alzheimer’s disease (AD) [87] (rs764971634, p.Ile437Val, P = 2 × 10 − 12 ), SQSTM1 and Paget’s disease [88] (rs104893941, p.Pro392Leu, P = 6 × 10 − 11 ), and HFE and disorders of iron metabolism [89] (rs1800562, p.Cys282Tyr, P = 1 × 10 − 178 ) (Fig.”
Hampshire, D. J., Burghel, G. J., Goudemand, J., Bouvet, L. C. S., Eikenboom, J. C. J., Schneppenheim, R., Budde, U., Peake, I. R., Goodeve, A. C., & groups, O. B. O. T. E.-V. A. Z.-V. S. (2010) · Haematologica · doi:10.3324/haematol.2010.027177 · Cited by 15
Laurier, E., Amiable, N., Gagnon, É., Brown, J. P., & Michou, L. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0495-3 · Cited by 16
Self-citationThe evaluation and treatment of Paget's disease of bone
Singer, F. R. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101506 · Cited by 15
A microscopic evaluation of Paget’s disease of bone from a Byzantine monastic crypt in Jordan
Kesterke, M. J., & Judd, M. A. (2018) · International Journal of Paleopathology · doi:10.1016/j.ijpp.2018.08.005 · Cited by 14
Rapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis
Whyte, M. P., Madson, K. L., Mumm, S. R., McAlister, W. H., Novack, D. V., Blair, J., Helliwell, T. R., Stolina, M., Abernethy, L. J., & Shaw, N. J. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2289 · Cited by 15
“Journal of Bone and Mineral Research RANK, and his radiographic findings did not match JPD.(14,35) Hence, we also excluded mutations in SQSTM1 associated with Paget’s bone disease (PBD)(20) and TNFSF11 (encoding RANKL) and sFRP1 (encoding frizzled related protein‐1, which binds RANKL and inhibits OC formation).”
BackgroundMethodInfluentialHasanain, M., Sahai, R., Pandey, P. K., Maheshwari, M., Choyal, K., Gandhi, D., Singh, A., Singh, K., Mitra, K., Datta, D. B., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12749 · Cited by 15
Li, W., Gao, H., Dong, X., & Zheng, D. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10283-x · Cited by 16
Ras and Rab Interactor 3: From Cellular Mechanisms to Human Diseases
Shen, R., Murphy, C. J., Xu, X., Hu, M., Ding, J., & Wu, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824961 · Cited by 19
“Mutations in Sequestosome 1 (SQSTM1)/p62 protein, a ubiquitin signaling and autophagy receptor, were first identified as a genetic cause of PDB (Hocking et al., 2002; Laurin et al., 2002).”
BackgroundMichou, L., Gamache, P., Guertin, J. R., Tarride, J., Brown, J. P., & Jean, S. (2023) · Bone · doi:10.1016/j.bone.2023.116895 · Cited by 14
Self-citationChen, I. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041490 · Cited by 17
“ARO 259,700 CLCN7 Chloride channel [26] ARO 259,700 OSTM1 GL [27] IARO 259,730 CAII Carbonic anhydrase II [12] ADOI 166,600 Lrp5 Lrp5 [28] ADOII 166,600 CLCN7 Chloride channel [29] Pycnodysostosis 265,800 CTSK Cathepsin K [14] PDB 6,002,080 SQSTM1 P62 [30,31] JPDB 239,000 TNFRSF11B Osteoprotegerin (OPG) [19] FEO 174,8…”
BackgroundDoes Antigen Masking by Ubiquitin Chains Protect from the Development of Autoimmune Diseases?
Weil, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00262 · Cited by 15
Enfermedad ósea de Paget: aproximación a sus orígenes históricos
Bueyes, L. R. M., & Fernández, M. D. C. S. (2016) · Reumatología Clínica · doi:10.1016/j.reuma.2016.02.008 · Cited by 15
Fungal, Viral, Multicelled Parasitic, and Protozoan Infections
Grauer, A. L., & Roberts, C. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809738-0.00012-0 · Cited by 15
Diagnosis and treatment of Paget's disease of bone: a mini-review
Ferraz‐de‐Souza, B., & Corrêa, P. H. S. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000800001 · Cited by 14
“From these, mutations in SQSTM1 (sequestosome 1, also known as p62), a multifunctional intracellular protein involved in ubiquitination and NF-kappa-B signaling, have been identified in sporadic and familial cases, and confer a higher risk of PDB (7,8).”
BackgroundSclerosing Bone Dysplasias: Leads Toward Novel Osteoporosis Treatments
Fijałkowski, I., Boudin, E., Mortier, G. R., & Hul, W. V. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0220-5 · Cited by 13
Daroszewska, A., Rose, L., Sarsam, N., Charlesworth, G., Prior, A., Rose, K., Ralston, S. H., & Hof, R. V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035576 · Cited by 13
“It is well established that osteoclasts and osteoclast precursors from patients with PDB, with or without the p62 P392L mutation, are hypersensitive to RANKL (Chamoux et al., 2009; Menaa et al., 2000; Neale et al., 2000).”
BackgroundInfluentialMontes, J. D. P., Corral-Gudino, L., Montilla Morales, C. A., & Castro, S. G. (2006) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(06)74349-1 · Cited by 11
Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations
Luís, E. O., Ortiz, A., Eudave, L., Ortega‐Cubero, S., Borroni, B., van der Zee, J., Gazzina, S., Caroppo, P., Rubino, E., D’Agata, F., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160006 · Cited by 13
“Less frequently, FTLD is caused by mutations in other genes such as the microtubule-associated protein tau gene (MAPT; OMIM#: 157140) [1], progranulin (GRN; OMIM#: 138945) [2], valosin containing protein (VCP; OMIM#: 601023), fused in sarcoma (FUS; OMIM#: 137070), TAr DNA-binding protein (TARDBP; OMIM#: 605078) gene,…”
BackgroundOptineurin regulates osteoblastogenesis through STAT1
Mizuno, N., Iwata, T., Ohsawa, R., Ouhara, K., Matsuda, S., Kajiya, M., Matsuda, Y., Kume, K., Tada, Y., Morino, H., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.028 · Cited by 15
miRNA-27a is essential for bone remodeling by modulating p62-mediated osteoclast signaling
Wang, S., Maruyama, E. O., Martinez, J. C., Lopes, J., Hsu, T., Wu, W., Hsu, W., & Maruyama, T. (2023) · eLife · doi:10.7554/elife.79768 · Cited by 15
“The gain- of-function mutations have linked p62 to the cause of Paget’s disease of bone – a genetic disorder characterized by aberrant osteoclastic activity ( Rea et al., 2006 ; Laurin et al., 2002 ).”
Gu, J., Zhang, Z., Zhang, H., Hu, W., Wang, C., Yue, H., Ke, Y., He, J., Hu, Y.-Q., Li, M., et al. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0352-6 · Cited by 16
“[14] and subsequently by Hocking et al.”
Development of a molecular test of Paget's disease of bone
Guay-Bélanger, S., Simonyan, D., Bureau, A., Gagnon, É., Albert, C., Morissette, J., Siris, E. S., Orcel, P., Brown, J. P., & Michou, L. (2016) · Bone · doi:10.1016/j.bone.2016.01.007 · Cited by 12
Self-citationPaget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy
Gennari, L., Rendina, D., Picchioni, T., Bianciardi, S., Materozzi, M., Nuti, R., & Merlotti, D. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1500691 · Cited by 18
“A unique proline– leucine amino-acid change at nucleotide position 1215, codon 392 (P392L) was first identified in 16 and 46% of sporadic and familial PDB subjects of French–Canadian origin from Quebec, respectively [52].”
BackgroundVCP/p97 increases BMP signaling by accelerating ubiquitin ligase Smurf1 degradation
Bailin, P. L., Cui, Y., Wei, J., Liu, C., Chen, Y., Cui, C., Li, L., Zhang, X., & Zhang, L. (2018) · The FASEB Journal · doi:10.1096/fj.201801173r · Cited by 12
“For example, sequestosome-1 (6, 7) and zinc finger protein 687 (8, 9) are the only genes that have been identified as responsible for the autosomal dominant form of PDB.”
BackgroundDisruption of ubiquitin-mediated processes in diseases of the brain and bone
Layfield, R., & Searle, M. S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360469 · Cited by 13
The Etiology of Paget's Disease of Bone: Viral and Genetic Interactions
Singer, F. R. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.014 · Cited by 12
“Furthermore, Paget’s disease occurs sporadically and in families with an autosomal dominant transmission pattern but with incomplete penetrance, due to mutations in the sequestosome 1 gene (Laurin et al., 2002).”
BackgroundGenetic Association Study of Dickkopf-1 and Sclerostin Genes with Paget Disease of Bone
Beauregard, M., Gagnon, É., Guay-Bélanger, S., Siris, E. S., Morissette, J., Brown, J. P., & Michou, L. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9762-2 · Cited by 12
Self-citationRusso, S., Scotto di Carlo, F., Maurizi, A., Fortunato, G., Teti, A., Licastro, D., Settembre, C., Mello, T., & Gianfrancesco, F. (2023) · Bone Research · doi:10.1038/s41413-023-00250-3 · Cited by 11
“The common form of PDB is due to mutations in the SQSTM1 gene, encoding the p62 protein, which is involved in important cellular mechanisms, such as autophagy or the regulation of the NFκB signaling pathway.(12,13) Mutations in SQSTM1 lead to an impaired and continuously activated NFκB pathway, resulting in more activ…”
BackgroundPaget's disease of bone: an update
Naot, D. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32834c3c0b · Cited by 11
Tao, X., Liu, L., Yang, X., Wei, Z., Chen, Z., Zhang, G., Zhang, Z., & Yue, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.850462 · Cited by 11
“Both patients harbored the relatively rare heterozygous identical mutation (M404T) in SQSTM1 instead of the most prevalent P392L PDB-causing mutation in the Caucasian population (21, 23, 24, 58).”
BackgroundDynamic expression and roles of sequestome‑1/p62 in LPS‑induced acute kidney injury in mice
Li, T., Zhao, J., Miao, S., Xu, Y., Xiao, X., & Liu, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8809 · Cited by 17
Shaik, N. A., Nasser, K. K., Alruwaili, M. M., Alallasi, S. R., Elango, R., & Banaganapalli, B. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1758212 · Cited by 15
“Positional cloning of 5q35 candidate locus have identified the strong role of coding region mutations in SQSTM1 gene among both sporadic and familial PDB patients of different ethnic back grounds (Laurin et al., 2002) (Guay-B elanger et al., 2015).”
BackgroundInfluentialEvolution and diversification of the nuclear envelope
Padilla-Mejía, N. E., Makarov, A. A., Barlow, L. D., Butterfield, E. R., & Field, M. C. (2021) · Nucleus · doi:10.1080/19491034.2021.1874135 · Cited by 14
Paget’s disease: Epidemiology and pathophysiology
Seton, M. (2008) · Current Osteoporosis Reports · doi:10.1007/s11914-008-0022-8 · Cited by 11
“Although epidemiologic evidence existed suggesting a genetic basis to Paget’s disease, it was not until 2002 that Laurin et al. [ 20 ] published their investigation of French-Canadian families with three generations of Paget’s disease.”
BackgroundInfluentialManifestations in a family with autosomal dominant bone fragility and limb‐girdle myopathy
Mehta, S. G., Watts, G. D. J., McGillivray, B., Mumm, S. R., Hamilton, S. J., Ramdeen, S. K., Novack, D. V., Briggs, C. E., Whyte, M. P., & Kimonis, V. E. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31008 · Cited by 11
“, 2002a], and SQSTM1 [Laurin et al., 2002] involved two living affected individuals (propositus plus one other) was performed using previously described methods.”
BackgroundMethodInfluentialSavarese, M., Jokela, M. E., & Udd, B. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00002-9 · Cited by 13
Falchetti, A., Marini, F., Laura, M., Amedei, A., & Luisa, B. M. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02312.x · Cited by 12
Corral-Gudino, L., del Pino‐Montes, J., García‐Aparicio, J., Alonso-Garrido, M., & González‐Sarmiento, R. (2010) · Cytokine · doi:10.1016/j.cyto.2010.07.008 · Cited by 12
Chapter 72. Paget's Disease of Bone
Siris, E. S., & Roodman, G. D. (2008) · Wiley eBooks · doi:10.1002/9780470623992.ch72 · Cited by 11
Wani, S., Daroszewska, A., Salter, D. M., Hof, R. V., Ralston, S. H., & Albagha, O. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049318 · Cited by 9
“…allele at the PML locus in predisposing to PDB is modest ( ∼ 1.34 fold) when compared with the susceptibility alleles at the SQSMT1 and OPTN loci, which are of considerably larger effect size, resulting in Mendelian forms of PDB (Hocking et al., 2002; Laurin et al., 2002; Obaid et al., 2015).”
InfluentialRossi, G., Salvi, E., Mehmeti, E., Ricci, M., Villa, C., Prioni, S., Moda, F., Fede, G. D., Tiraboschi, P., Redaelli, V., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1085406 · Cited by 11
“SQSTM1 mutations were firstly identified as causative of Paget Disease of Bone (PDB; Laurin et al., 2002), and afterwards this gene was disclosed to be also causative of ALS (Fecto et al.”
BackgroundCazzaro, S., Zhao, X., Zhao, V. K., Kim, Y. K., & Woo, J. A. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad006 · Cited by 9
Siris, E. S., & Roodman, G. D. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch80 · Cited by 13
Dessay, M., Couture, E., Maaroufi, H., Fournier, F., Gagnon, É., Droit, A., Brown, J. P., & Michou, L. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01198-9 · Cited by 8
Self-citationShanmugarajan, S., Youssef, R. F., Pati, P., Ries, W. L., Rao, D. S., & Reddy, S. V. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21723 · Cited by 8
“Although recurrent mutations occur in the UBA domain of Sequestosome 1 (SQSTM1/ p62) in patients with PD [Laurin et al., 2002; Layfield et al., 2004], recent evidence indicated that mutant p62 expression is not sufficient to induce pagetic phenotype in OCL, but may cause a predisposition to the…”
BackgroundSeton, M., Hansen, M. F., & Solomon, D. H. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-0103-5 · Cited by 8
“The most prevalent mutation P392L results from a T to C transition in position 1215 in SQSTM1 [5].”
BackgroundSun, L., Rong, Z., Li, W., Zheng, H., Xiao, S., & Li, X. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00026 · Cited by 10
“, 2015), is initially considered as a monogenic cause of Paget disease of bone (PDB) in 2002 (Laurin et al., 2002) and amyotrophic lateral sclerosis in 2011 (Fecto et al.”
BackgroundWhite, G., & Rushbrook, J. L. (2013) · Orthopaedics and Trauma · doi:10.1016/j.mporth.2013.07.001 · Cited by 10
Homozygous SQSTM1 nonsense variant identified in a patient with brainstem involvement
Kılıç, M. A., Kipoğlu, O., Coşkun, O., Karacabey, B. N., Yeşilyurt, A., Yıldız, E. P., Aydınli̇, N., & Caliskan, M. M. (2021) · Brain and Development · doi:10.1016/j.braindev.2021.06.001 · Cited by 8
Gendron, E., Bouchard, F., Singbo, N., Brown, J. P., & Michou, L. (2023) · Bone · doi:10.1016/j.bone.2023.116721 · Cited by 8
Self-citationCervical Paget Disease of Bone With Spinal Cord Compression Due to Atlanto-Axial Instability
Tessitore, E., Luzi, M., Lobrinus, J. A., Samaras, N., & Trombetti, A. (2008) · Spine · doi:10.1097/brs.0b013e3181624bad · Cited by 8
“Laurin et al have mapped in 2002 a mutation on 5q35-QTER, which encodes sequestasome-1, and subsequent studies suggested that that 30% to 50% of familial PDB and 9% to 20% of sporadic forms might arise from mutation of that gene.(8) After the pelvis and the long bones, the spine is the second most common site of invol…”
BackgroundSundaram, K., Senn, J. J., & Reddy, S. V. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24554 · Cited by 9
“PDB is an autosomal dominant trait with genetic heterogeneity and recurrent mutations have been identified in sequestome 1 (SQSTM1/ p62) ubiquitin‐associated (UBA) domain [Laurin et al., 2002].”
BackgroundWang, W., Feng, W., Li, D., Liu, S., Gao, Y., Zhao, Z., Fu, Q., Yan, L., Zheng, W., Li, M., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.020 · Cited by 8
La enfermedad de Paget: la historia interminable
Montes, J. D. P. (2007) · Reumatología Clínica · doi:10.1016/s1699-258x(07)73626-4 · Cited by 8
Langston, A. L., Johnston, M., Robertson, C., Campbell, M., Entwistle, V. A., Marteau, T. M., McCallum, M., & Ralston, S. H. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-71 · Cited by 10
“Genotype-phenotype analysis has shown that SQSTM1 mutations are highly penetrant, such that between 90– 100% of individuals within families who carry mutations will have developed the disease by the age of 65 years [ 7- 11 ].”
BackgroundAutophagy: mechanisms, roles in human diseases, and therapeutic perspectives
He, J., & Qi, T. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1776289 · Cited by 8
miR profile in pagetic osteoclasts: from large-scale sequencing to gene expression study
Nguyen, H. D., Bisson, M., Scott, M. S., Boire, G., Bouchard, L., & Roux, S. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02128-5 · Cited by 8
Şimşek, S., Basoski, N., Bravenboer, N., Zhang, X., Mumm, S. R., Whyte, M. P., & Netelenbos, J. C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0479 · Cited by 7
“Two heterozygous polymorphisms were detected in exon 6 (916C T, E292E; 976G A, R312R) (24).”
BackgroundInfluentialCrego-Vita, D., Aedo-Martín, D., & Sánchez-Pérez, C. (2016) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2016.05.050 · Cited by 8
Matthews, B. G., & Cundy, T. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.43 · Cited by 8
Cosso, R., Nuzzo, V., Zuccoli, A., Brandi, M. L., & Falchetti, A. (2010) · PubMed · Cited by 9
Nájera, M., Usategui‐Martín, R., Lobato-Carrasco, J., González, M. D.-G., Mirón-Canelo, J. A., Miramontes‐González, J. P., Ralston, S. H., & Corral-Gudino, L. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf280 · Cited by 7
Peeters, J. J. M., Ridder, R. D., Hamoen, E. C., Eekhoff, E. M. W., Smit, F., Boudin, E., Hul, W. V., Papapoulos, S. E., & Appelman‐Dijkstra, N. M. (2019) · Bone · doi:10.1016/j.bone.2019.115044 · Cited by 7
Tucci, J. R. (2004) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000140923.88339.11 · Cited by 7
HEREDITARY AND FAMILIAL SYNDROMES OF BONE AND BLOOD. GENETIC PATHWAYS, DIAGNOSTIC PITFALLS
Rossbach, H. (2007) · Fetal and Pediatric Pathology · doi:10.1080/15513810701394777 · Cited by 6
“Mutations in the TNFRSF11A gene [72] or in the SQSTM1gene [73] result in abnormalities of the RANK pathway essential in osteoclast formation.”
BackgroundRidder, R. D., Boudin, E., Vandeweyer, G., Devogelaer, J., Fransén, E., Mortier, G. R., & Hul, W. V. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00530-3 · Cited by 6
C9ORF72 hexanucleotide repeat expansion frequency in patients with Paget's disease of bone
Rubino, E., Stefano, M. D., Galimberti, D., Serpente, M., Scarpini, E. A., Fenoglio, C., Bo, M., & Rainero, I. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.014 · Cited by 7
“To date, causative PDB mutations have been identified mainly in the SQSTM1 gene, coding for the p62 protein, with a frequency of 25–50% in familial and 5–10% in sporadic patients (Laurin et al., 2002).”
BackgroundAmyotrophic Lateral Sclerosis 1 and Many Diseases
Ratti, E., & Berry, J. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00042-1 · Cited by 6
Faccio, R., Choi, Y., Teitelbaum, S. L., & Takayanagi, H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10006-8 · Cited by 12
Metadata
- Authors
- Laurin, N., Brown, J. P., Morissette, J., & Raymond, V.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Raymond, Vincent
- ORCID
- Brown, Jacques P.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 70
- Issue
- 6
- Pages
- 1582-1588
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC379146
- OpenAlex
- W2011308707
- Cited by
- 563
- References
- 47
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 10 · 2023: 23 · 2022: 14 · 2021: 19 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 14 · 2016: 34 · 2015: 28 · 2014: 35 · 2013: 30 · 2012: 31
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4066 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds pour la Formation de Chercheurs et l'Aide à la Recherche
- Canadian Institutes of Health Research (MOP-3804)
- Fonds de Recherche du Québec - Santé
- Canada Foundation for Innovation (548)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Keywords
- Paget's disease of bone, p62, recurrent mutations, ubiquitin-associated domain, haplotype mapping, French-Canadian families, NF-κB signaling, genetic susceptibility, bone turnover
- MeSH terms
- Sequestosome-1 Protein, Base Sequence, Canada, Carrier Proteins, France, Genetic Testing, Haplotypes, Heterozygote, Homozygote, Humans, Molecular Sequence Data, Mutation, Osteitis Deformans, Proteins, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.